Pharmacologic treatment of cardiac arrest
- PMID: 10534025
- DOI: 10.1080/10903129908958954
Pharmacologic treatment of cardiac arrest
Abstract
Antiarrhythmic drugs currently recommended in the American Heart Association's Advanced Cardiac Life Support (ACLS) guidelines for the treatment of cardiac arrest have not been proved in controlled clinical trials to improve survival in patients with ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT). Intravenous amiodarone is a promising agent for the treatment of VF and VT. Based on available evidence, amiodarone should be considered for use in patients with shock-refractory ventricular arrhythmias.
Similar articles
-
Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).Circulation. 2017 Nov 28;136(22):2119-2131. doi: 10.1161/CIRCULATIONAHA.117.028624. Epub 2017 Sep 13. Circulation. 2017. PMID: 28904070 Free PMC article. Clinical Trial.
-
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.N Engl J Med. 2016 May 5;374(18):1711-22. doi: 10.1056/NEJMoa1514204. Epub 2016 Apr 4. N Engl J Med. 2016. PMID: 27043165 Clinical Trial.
-
Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia.J Formos Med Assoc. 2020 Jan;119(1 Pt 2):327-334. doi: 10.1016/j.jfma.2019.05.023. Epub 2019 Jun 27. J Formos Med Assoc. 2020. PMID: 31255419
-
Amiodarone supplants lidocaine in ACLS and CPR protocols.Anesthesiol Clin. 2011 Sep;29(3):535-45. doi: 10.1016/j.anclin.2011.05.001. Anesthesiol Clin. 2011. PMID: 21871409 Review.
-
Prehospital management of cardiac arrest: how useful are vasopressor and antiarrhythmic drugs?Prehosp Emerg Care. 2002 Jan-Mar;6(1):72-80. doi: 10.1080/10903120290938878. Prehosp Emerg Care. 2002. PMID: 11789656 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical